Literature DB >> 19222434

Goodbye suxamethonium!

C Lee1.   

Abstract

No drugs in anaesthesia are more problematic than suxamethonium. Yet, no drugs have survived as suxamethonium does in spite of crisis after crisis, and attempt after attempt at its replacement. For decades, suxamethonium has taught us neuromuscular pharmacology and provided us with an encyclopaedia of side effects, while benefiting millions and millions of our anaesthetised patients. With the arrival of sugammadex, it finally appears that suxamethonium can be retired. Suxamethonium has done its job and seen its days! The present review is intended to offer a eulogy for suxamethonium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19222434     DOI: 10.1111/j.1365-2044.2008.05873.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  10 in total

1.  Succinylcholine and morbid obesity: the debate continues...

Authors:  Jay B Brodsky; Harry J M Lemmens
Journal:  Obes Surg       Date:  2009-10-08       Impact factor: 4.129

2.  Use of rocuronium-sugammadex, an alternative to succinylcholine, as a muscle relaxant during electroconvulsive therapy.

Authors:  Hiroko Hoshi; Yuji Kadoi; Jiro Kamiyama; Akiko Nishida; Hiroyuki Saito; Masaki Taguchi; Shigeru Saito
Journal:  J Anesth       Date:  2011-02-04       Impact factor: 2.078

3.  Suxamethonium or rocuronium for rapid sequence induction of anaesthesia?

Authors:  W J Fawcett
Journal:  BJA Educ       Date:  2019-10-22

4.  Comparison of recovery times from rocuronium-induced muscle relaxation after reversal with three different doses of sugammadex and succinylcholine during electroconvulsive therapy.

Authors:  Yuji Kadoi; Hiroko Hoshi; Akiko Nishida; Shigeru Saito
Journal:  J Anesth       Date:  2011-09-24       Impact factor: 2.078

5.  Modified rapid sequence induction and intubation: a survey of United States current practice.

Authors:  Jesse M Ehrenfeld; Eva A Cassedy; Victoria E Forbes; Nathaniel D Mercaldo; Warren S Sandberg
Journal:  Anesth Analg       Date:  2011-10-24       Impact factor: 5.108

6.  Use of Succinylcholine by Anaesthetists in Turkey: A National Survey.

Authors:  Dilek Ömür; Hasan Ali Kiraz; Hasan Şahin; Hüseyin Toman; Berna Uyan; Serpil Ekin; Volkan Hancı
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-08-21

7.  Supramolecular therapeutics to treat the side effects induced by a depolarizing neuromuscular blocking agent.

Authors:  Xiangjun Zhang; Qian Cheng; Lanlan Li; Liqing Shangguan; Chenwen Li; Shengke Li; Feihe Huang; Jianxiang Zhang; Ruibing Wang
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

8.  Comparison of emergence agitation between succinylcholine and rocuronium-sugammadex in adults following closed reduction of a nasal bone fracture: a prospective randomized controlled trial.

Authors:  Seok-Jin Lee; Tae-Yun Sung; Choon-Kyu Cho
Journal:  BMC Anesthesiol       Date:  2019-12-16       Impact factor: 2.217

9.  Pretreatment of magnesium sulphate improves intubating conditions of rapid sequence tracheal intubation using alfentanil, propofol, and rocuronium - a randomized trial.

Authors:  Seong-Joo Park; Youn-Joung Cho; Ji-Hye Oh; Jung-Won Hwang; Sang-Hwan Do; Hyo-Seok Na
Journal:  Korean J Anesthesiol       Date:  2013-09-25

10.  Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports.

Authors:  Usha Gurunathan; Shakeel Meeran Kunju; Lisa May Lin Stanton
Journal:  BMC Anesthesiol       Date:  2019-11-19       Impact factor: 2.217

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.